DELL'ORO, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 9.600
EU - Europa 4.901
AS - Asia 2.676
SA - Sud America 171
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 17.387
Nazione #
US - Stati Uniti d'America 9.462
SG - Singapore 1.168
RU - Federazione Russa 832
IT - Italia 821
SE - Svezia 799
DE - Germania 765
CN - Cina 688
IE - Irlanda 635
HK - Hong Kong 513
UA - Ucraina 368
GB - Regno Unito 210
BR - Brasile 149
CA - Canada 123
AT - Austria 113
FI - Finlandia 108
VN - Vietnam 66
FR - Francia 64
IN - India 59
ID - Indonesia 51
NL - Olanda 48
DK - Danimarca 39
BE - Belgio 27
TR - Turchia 26
JP - Giappone 24
CZ - Repubblica Ceca 17
IR - Iran 10
MX - Messico 9
RO - Romania 8
UZ - Uzbekistan 8
AU - Australia 7
EU - Europa 7
KE - Kenya 7
LK - Sri Lanka 7
IQ - Iraq 6
LT - Lituania 6
PH - Filippine 6
PL - Polonia 6
BG - Bulgaria 5
CL - Cile 5
EC - Ecuador 5
KR - Corea 5
PE - Perù 5
PK - Pakistan 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
CH - Svizzera 4
MY - Malesia 4
VE - Venezuela 4
AM - Armenia 3
AR - Argentina 3
DO - Repubblica Dominicana 3
ES - Italia 3
GR - Grecia 3
MU - Mauritius 3
PT - Portogallo 3
TN - Tunisia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
MG - Madagascar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
SA - Arabia Saudita 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.387
Città #
Ann Arbor 1.870
Fairfield 898
Woodbridge 884
Singapore 759
Dublin 610
Houston 608
Chandler 587
Frankfurt am Main 525
Hong Kong 510
Wilmington 461
Ashburn 431
Jacksonville 402
Seattle 341
Dearborn 267
New York 267
Cambridge 235
Milan 235
Princeton 210
Santa Clara 209
Nanjing 107
Lawrence 104
Vienna 97
Altamura 94
Beijing 94
Shanghai 88
Lachine 63
San Diego 56
Moscow 52
Jakarta 46
Lissone 46
Council Bluffs 41
Nanchang 41
Dong Ket 40
Helsinki 36
Boardman 34
Guangzhou 33
Andover 32
Shenyang 31
Hebei 30
Changsha 27
London 26
Fremont 25
Los Angeles 25
Falls Church 24
Rome 23
Toronto 23
Brussels 22
Nuremberg 21
Tianjin 21
Jinan 20
Jiaxing 19
Norwalk 19
Kunming 18
Monza 18
Munich 17
Ningbo 17
Ottawa 17
Hangzhou 16
Sacramento 15
Brno 14
Cinisello Balsamo 14
Nürnberg 14
Hefei 13
San Mateo 13
São Paulo 12
Huizen 11
Zhengzhou 11
Auburn Hills 10
Pune 10
Düsseldorf 8
Edmonton 8
Fuzhou 8
Padova 8
Philadelphia 8
Redmond 8
Amsterdam 7
Busto Arsizio 7
Groningen 7
Lappeenranta 7
San Francisco 7
Tashkent 7
Belo Horizonte 6
Bergamo 6
Carate Brianza 6
Colombo 6
Detroit 6
Kiev 6
Leawood 6
Malgesso 6
Mountain View 6
Rio de Janeiro 6
Romola 6
University Park 6
Winnipeg 6
Akatsuka-shinmachi 5
Campinas 5
Dallas 5
Esslingen am Neckar 5
Hyderabad 5
Manila 5
Totale 12.207
Nome #
Heart rate as a sympathetic marker during acute adrenergic challenge 311
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 280
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 255
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 241
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 206
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 203
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 200
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms 199
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 199
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 198
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 198
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure state 197
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 197
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 196
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 196
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 195
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 193
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 193
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 190
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 184
Neurogenic abnormalities in masked hypertension 182
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 182
Adrenergic and reflex abnormalities in obesity-related hypertension 181
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 181
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 180
Threshold and Target for Blood Pressure Lowering in the Elderly 180
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 179
Role of ambulatory blood pressure monitoring in resistant hypertension 179
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 178
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 176
Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly 173
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 173
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 172
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 171
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 170
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 167
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 164
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 163
Extreme dipping: Always means nocturnal hypotension? 163
Diurnal blood pressure variation and sympathetic activity 162
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 160
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 159
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 158
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 157
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 154
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 154
How to assess sympathetic nervous system activity in clinical practice 151
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 150
Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity 149
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 147
Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias 146
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 146
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 146
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 144
Early sympathetic activation in the initial clinical stages of chronic renal failure 142
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 142
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 141
Baroreflex activation therapy systems: current status and future prospects 140
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 139
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome: Is there any role for obstructive sleep apnea? 138
Salt intake and sympathetic activity - Response 138
The "J curve" problem revisited: old and new findings 135
Left ventricular hypertrophy in isolated and dual masked hypertension 134
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 134
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 133
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 130
Sympathetic activation in obesity: a noninnocent bystander 128
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 128
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 127
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 127
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 126
Predictive value of different indices of blood pressure variability on 126
Long-term changes in left ventricular mass echocardiographic findings from a general population 125
Blood pressure control and antihypertensive treatment 124
Retinal arteriolar narrowing as marker of renal dysfunction: potential value and limitations 124
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? 121
Essential hypertension and the sympathetic nervous system 120
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 120
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 119
Antihypertensive treatment and stroke prevention: From recent meta-analyses to the PRoFESS trial 119
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 117
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 116
Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement 116
Adverse prognostic value of persistent office blood pressure elevation in White coat Hypertension 110
The PAMELA research project: a 25-year long journey 110
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 107
The neglected role of the electrocardiogram in the diagnostic work-up of hypertensive patients: a study in clinical practice 106
Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study 104
Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome 102
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 102
Metabolic syndrome and cardiometabolic risk: An update 101
Vascular inflammation and aortic stiffness relate to early left ventricular diastolic dysfunction in prehypertension 101
Effects of long-term Baroreflex activation in congestive heart failure 100
Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project 100
Prognosti relevance of electrocardiographic tp-te interval in the general and in the hypertensive population: data from the pamela study 92
Incident aortic root dilatation in the general population: findings from the Pamela study. 86
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 86
Nocturnal blood pressure: the dark side of white-coat hypertension 82
Effects of renal denervation on asymmetric dimethylarginine and sympathetic nerve traffic in resistant hypertensive patients 80
Amiodarone induced siadh: A case of rare and late onset side effects 80
Totale 15.206
Categoria #
all - tutte 73.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020382 0 0 0 0 0 0 0 0 0 164 160 58
2020/20212.263 140 123 204 220 164 211 240 225 186 242 116 192
2021/20221.700 147 125 235 183 138 128 71 68 95 110 163 237
2022/20232.510 270 708 231 253 150 408 41 155 140 34 80 40
2023/20242.062 51 54 89 112 285 491 388 61 224 39 41 227
2024/20253.673 329 665 231 251 467 161 288 280 536 465 0 0
Totale 17.966